Company profile for ZACH System SA

PharmaCompass

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Related CompaniesRelated Companies

About

Zach System, a subsidiary of Zambon Company, specializes in providing active pharmaceutical ingredients (APIs), intermediates and custom synthesis services that align with customers’ schedules and budget targets. It offers a diverse range of products and services for the generic drugs market, including producing APIs for Zambon Pharma and offering process development expertise to customers. Its facility in Avrillè, France, is cGMP compliant and approved by the FDA. The facility boasts reactors ranging from 50 litres to 10,000 litres, advanced technologies, and a state-of-the-art R&D center and QC labs, as well as a dedicated sales team.

CONTACT DETAILS

Click the arrow to open the dropdown

Events

Webinars & Exhibitions

CPHI Middle east

CPHI Middle east

Not Confirmed

envelop Contact Supplier

CPHI Middle east

Post an Enquiry

Meeting

Digital content read-more

Explore the latest content creation from this company

CORPORATE CONTENT #SupplierSpotlight

    https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-75640.pdf

    https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-1583380114.pdf

    https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-12292.pdf

    https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-62046.pdf

    https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-1063.pdf

    https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-1657779912.pdf

    https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-1632832010.pdf

NEWS #PharmaBuzz

read-more
read-more

https://www.zambon.com/sites/default/files/press/files/2024-09/open-accelerator-announces-5-startups-2024-program.pdf

PRESS RELEASE
10 Oct 2024

https://www.zambon.com/en/media/press/2024-09-24-zcube-zambon-research-venture-leads-c2-million-investment-round-canadian

PRESS RELEASE
24 Sep 2024

https://www.zambon.com/sites/default/files/press/files/2024-09/240913_global_zambon_lancet-promis-1.pdf

PRESS RELEASE
13 Sep 2024

https://www.zambon.com/en/media/press/2024-05-02-giovanni-magnaghi-new-chief-executive-officer-zambon-spa

PRESS RELEASE
02 May 2024

https://www.zambon.com/sites/default/files/press/files/2024-02/240227_ENG_Open%20Accelerator%202024%20Launch_DEF.pdf

PRESS RELEASE
27 Feb 2024

https://www.zambon.com/en/media/press/2024-02-27-amneal-enters-exclusive-european-licensing-agreement-zambon-biotech-ipx203

PRESS RELEASE
27 Feb 2024

01

Acetylcysteine

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
CPHI Middle east
Not Confirmed
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Not Available For Sales AUDIT
Zach System VB Company banner

02

Bosentan Hydrate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
CPHI Middle east
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF ASMF arrow-down AUDIT
Zach System VB Company banner

03

Fosfomycin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
CPHI Middle east
Not Confirmed
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Not Available For Sales AUDIT
Zach System VB Company banner

04

Loteprednol Etabonate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
CPHI Middle east
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down